IMR Press / FBL / Volume 29 / Issue 4 / DOI: 10.31083/j.fbl2904149
Open Access Original Research
Exosomal CircRNAs in Circulation Serve as Diagnostic Biomarkers for Acute Myocardial Infarction
Xiaoyan Liu1,2,3,†Yeping Zhang1,2,†Wen Yuan3Ruijuan Han4Jiuchang Zhong1,2Xinchun Yang1,2,*Meili Zheng1,2,*Boqia Xie1,2,5,*
Show Less
1 Heart Center and Beijing Key Laboratory of Hypertension, Beijing Chao-Yang Hospital, Capital Medical University, 100020 Beijing, China
2 Department of Cardiology, Beijing Chao-Yang Hospital, Capital Medical University, 100020 Beijing, China
3 Medical Research Center, Beijing Institute of Respiratory Medicine and Beijing Chao-Yang Hospital, Capital Medical University, 100020 Beijing, China
4 Department of Cardiology, The Second Affiliated Hospital, School of Medicine, The Chinese University of Hong Kong, Shenzhen & Longgang District People's Hospital of Shenzhen, 518172 Shenzhen, Guangdong, China
5 Department of Cardiac Surgery, Beijing Chaoyang Hospital, Capital Medical University, 100020 Beijing, China
*Correspondence: 15896053808@163.com (Xinchun Yang); zhengmeilicyh@mail.ccmu.edu.cn (Meili Zheng); dr.boqiaxie@mail.ccmu.edu.cn (Boqia Xie)
These authors contributed equally.
Front. Biosci. (Landmark Ed) 2024, 29(4), 149; https://doi.org/10.31083/j.fbl2904149
Submitted: 18 November 2023 | Revised: 6 February 2024 | Accepted: 21 February 2024 | Published: 11 April 2024
Copyright: © 2024 The Author(s). Published by IMR Press.
This is an open access article under the CC BY 4.0 license.
Abstract

Background: The diagnostic potential of circular RNAs (circRNAs) in circulating exosomes for acute myocardial infarction (AMI) is not well understood, despite existing research indicating their role in cardiovascular diseases. This study aimed to clarify the significance of exosomal circular RNAs as indicators for AMI. Methods: We examined 120 individuals diagnosed with AMI and 83 individuals with non-cardiogenic chest pain (NCCP), all previously enrolled in a conducted study. High-throughput sequencing to identify differentially expressed circRNAs in the circulating exosomes of AMI patients. To validate, we employed Real-Time polymerase chain reaction (RT-PCR) targeting five circRNAs that exhibited notable increase. Results: The sequencing identified 893 exosomal circRNAs with altered expression in AMI patients, including 118 up-regulated and 775 down-regulated circRNAs. Genes linked to these circRNAs were enriched in crucial Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways, highlighting their direct relevance to AMI pathophysiology. Three exosomal circRNAs (hsa_circ_0001558, hsa_circ_0001535, and hsa_circ_0000972) showed significant up-regulation in AMI patients during the initial validation cohort. The corresponding area under the curve (AUC) values were 0.79, 0.685, and 0.683, respectively. Further validation of hsa_circ_0001558 in a second cohort showed a 4.45-fold increase in AMI patients, with AUC = 0.793. The rise was particularly noticeable in patients with non-ST-elevation myocardial infarction (NSTEMI) (2.80 times, AUC = 0.72) and patients with ST-elevation myocardial infarction (STEMI) (5.27 times, AUC = 0.831) compared to patients with NCCP. Conclusions: Our findings demonstrate significant differences in the expression patterns of circRNAs in plasma exosomes between AMI patients and NCCP patients. Specifically, hsa_circ_0001558 appears as a promising indicator for AMI diagnosis. Further research is necessary to fully evaluate the diagnostic potential of exosomal circRNAs in the context of AMI, emphasizing the importance of these findings.

Keywords
acute myocardial infarction
exosome
circRNA
biomarkers
Funding
82170302/General Program of the National Natural Science Foundation of China
7222068/2024 Reform and Development Program of Beijing Institute of Respiratory Medicine
CYFH202209/Clinical Research Incubation Program of Beijing Chaoyang Hospital Affiliated to Capital Medical University
Figures
Fig. 1.
Share
Back to top